{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:09:37Z","timestamp":1772168977266,"version":"3.50.1"},"reference-count":31,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004071","name":"Khon Kaen University","doi-asserted-by":"publisher","award":["KE61020"],"award-info":[{"award-number":["KE61020"]}],"id":[{"id":"10.13039\/501100004071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"\n Background:<\/ns4:bold>\n Proton pump inhibitors are effective for functional dyspepsia but ineffective in relieving postprandial distress syndrome.\n Curcuma longa<\/ns4:italic>\n might be effective for postprandial distress syndrome. The objective of this study was to compare the efficacy of\n Curcuma longa<\/ns4:italic>\n and simethicone for postprandial distress syndrome in an open-label randomized-controlled trial.\n <\/ns4:p>\n \n Methods:<\/ns4:bold>\n This trial was conducted between July 2018 and February 2019. In total, 78 patients were randomly assigned to receive 4 weeks of treatment with 750 or 1,500 mg oral\n Curcuma longa<\/ns4:italic>\n per day or 240 mg simethicone per day. The patients assessed their symptoms using the dyspepsia Global Overall Symptom scale at baseline, week 2, and week 4. After stopping medication for 2 weeks, the patients assessed recurrent symptoms and day of recurrence by themselves at the end of week 6.\n <\/ns4:p>\n \n Results:<\/ns4:bold>\n In total, 78 patients underwent randomization (27 in 750 mg\n Curcuma longa<\/ns4:italic>\n , 26 in 1500 mg\n Curcuma longa<\/ns4:italic>\n , and 25 in simethicone groups). After 2 weeks, there were no significant differences in all mean changes of symptoms scores (95%CI) of postprandial distress syndrome [-4.1 (-4.5, -2.6) vs -4.3 (-5.2, -3.3) vs -4.2 (-4.8, -3.5), P=0.954]. Over a period of 4 weeks, the reduction in mean scores was greater among participants receiving simethicone (although not statistically significant) compared with two intervention groups [-4.6 (-5.7, -3.6) vs -5.4 (-6.6, -4.1) vs -6.2 (-7.2, -5.2), P=0.122]. The rate of recurrence was significantly lower in simethicone than the two\n Curcuma longa<\/ns4:italic>\n groups (42.9 vs 45.5 vs 13.6%, P=0.047). There was no serious adverse event reported in all three groups.\n <\/ns4:p>\n \n Conclusions:<\/ns4:bold>\n Curcuma longa<\/ns4:italic>\n had a similar effect on treatment outcomes to simethicone after 2 and 4 weeks, but the recurrence rate of symptoms was significantly higher without serious adverse events.\n <\/ns4:p>\n \n Registration:<\/ns4:bold>\n Registered with the Thai Clinical Trials Registry on 31 January 2018;\n TCTR20180131001<\/ns4:ext-link>\n .\n <\/ns4:p>","DOI":"10.12688\/f1000research.20662.1","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T07:25:07Z","timestamp":1572420307000},"page":"1827","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of Curcuma longa in treatment of postprandial distress syndrome: An open-label randomized-controlled trial"],"prefix":"10.12688","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3653-3314","authenticated-orcid":false,"given":"Nicharat","family":"Sawangroj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiratha","family":"Budkaew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1214-1962","authenticated-orcid":false,"given":"Bandit","family":"Chumworathayi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"1049-1057","DOI":"10.1136\/gutjnl-2014-307843","article-title":"Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis.","volume":"64","author":"A Ford","year":"2015","journal-title":"Gut."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"321-327","DOI":"10.1136\/gut.2006.099846","article-title":"Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study.","volume":"56","author":"A Ford","year":"2007","journal-title":"Gut."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"714-723","DOI":"10.1111\/j.1365-2036.2011.04789.x","article-title":"Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study.","volume":"34","author":"S van Zanten","year":"2011","journal-title":"Aliment Pharmacol Ther."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"170-177","DOI":"10.1111\/apt.12355","article-title":"Functional dyspepsia: the economic impact to patients.","volume":"38","author":"B Lacy","year":"2013","journal-title":"Aliment Pharmacol Ther."},{"key":"ref-5","article-title":"Guideline for the management of dyspepsia and Helicobacter pylori 2010.","year":"2010"},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"1380-1392","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal Disorders.","volume":"150","author":"V Stanghellini","year":"2016","journal-title":"Gastroenterology."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"268-270","DOI":"10.1055\/s-2007-1010479","article-title":"Randomized placebo-controlled trial of oral liquid simethicone prior to upper gastrointestinal endoscopy.","volume":"24","author":"G Bertoni","year":"1992","journal-title":"Endoscopy."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"380-387","DOI":"10.1159\/000286002","article-title":"Review of the therapeutic use of simethicone in gastroenterology.","volume":"19","author":"R Meier","year":"2007","journal-title":"Schweiz Zschr GanzheitsMedizin."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"207-211","DOI":"10.1002\/jat.2550140311","article-title":"Mechanism of antifoaming action of simethicone.","volume":"14","author":"L Brecevi\u0107","year":"1994","journal-title":"J Appl Toxicol."},{"key":"ref-10","first-page":"259-263","article-title":"Etiology and management of gastrointestinal gas.","volume":"32","author":"J Wess","year":"1978","journal-title":"GEN."},{"key":"ref-11","first-page":"198-208","article-title":"Flatulence: pathophysiology and treatment.","volume":"31","author":"M Van Ness","year":"1985","journal-title":"Am Fam Physician."},{"key":"ref-12","first-page":"148-154","article-title":"Accelerated transit of intestinal gas with simethicone.","volume":"44","author":"I Danhof","year":"1974","journal-title":"Obstet Gynecol."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"379-381","DOI":"10.1007\/bf00558299","article-title":"Use of dimethicone to reduce the fall in gastric potential difference induced by bile salts.","volume":"36","author":"J Bergmann","year":"1989","journal-title":"Eur J Clin Pharmacol."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"1459-1465","DOI":"10.1046\/j.1365-2036.1999.00644.x","article-title":"Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia.","volume":"13","author":"G Holtmann","year":"1999","journal-title":"Aliment Pharmacol Ther."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"1641-1648","DOI":"10.1046\/j.1365-2036.2002.01322.x","article-title":"A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia.","volume":"16","author":"G Holtmann","year":"2002","journal-title":"Aliment Pharmacol Ther."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"478-84","DOI":"10.1016\/j.gcb.2008.09.021","article-title":"Efficacy of an activated charcoal-simethicone combination in dyspeptic syndrome: Results of a placebo-controlled prospective study in general practice.","volume":"33","author":"M Lecuyer","year":"2009","journal-title":"Gastroenterol Clin Biol."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"494-9","DOI":"10.1016\/j.clinre.2011.02.009","article-title":"Efficacy of a simethicone, activated charcoal and magnesium oxide combination (Carbosymag\u00ae) in functional dyspepsia: Results of a general practice-based randomized trial.","volume":"35","author":"B Coffin","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol."},{"key":"ref-18","first-page":"613-20","article-title":"Randomized double blind study of Curcuma domestica Val. for dyspepsia.","volume":"72","author":"V Thamlikitkul","year":"1989","journal-title":"J Med Assoc Thai."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"314-20","DOI":"10.1016\/j.intimp.2013.06.020","article-title":"Curcumin ameliorates dextran sulfate sodium-induced experimental colitis by blocking STAT3 signaling pathway.","volume":"17","author":"L Liu","year":"2013","journal-title":"Int Immunopharmacol."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"102-9","DOI":"10.1055\/s-0032-1328057","article-title":"Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4\/NF-\u03baB signaling pathway.","volume":"79","author":"Z Zeng","year":"2013","journal-title":"Planta Med."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"249-255","DOI":"10.1159\/000336720","article-title":"Curcumin and inflammatory bowel disease: biological mechanisms and clinical implication.","volume":"85","author":"T Ali","year":"2012","journal-title":"Digestion."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11894-016-0494-0","article-title":"Chili Peppers, Curcumins, and Prebiotics in Gastrointestinal Health and Disease.","volume":"18","author":"T Patcharatrakul","year":"2016","journal-title":"Curr Gastroenterol Rep."},{"key":"ref-23","first-page":"261-262","article-title":"Comparative efficacy of curcuma longa and ranitidine in patients with uninvestigated dyspepsia.","author":"S Sirijarugul","year":"2008","journal-title":"Proceedings of The Eighth Joint Sminar Innovative Research in Natural Products for Sustainable Development."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"444-8","DOI":"10.1055\/s-0042-109394","article-title":"Adjunctive Therapy with Curcumin for Peptic Ulcer: a Randomized Controlled Trial.","volume":"66","author":"A Khonche","year":"2016","journal-title":"Drug Res (Stuttg)."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"521-9","DOI":"10.1111\/j.1365-2036.2006.02774.x","article-title":"Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials.","volume":"23","author":"S Veldhuyzen van Zanten","year":"2006","journal-title":"Aliment Pharmacol Ther."},{"key":"ref-26","article-title":"Sample Size Calculations in Clinical Research, 2nd edition","author":"S Chow","year":"2008"},{"key":"ref-27","article-title":"CurcumaUnderlyingData and CurcumaCONSORTchecklist.","author":"N Sawangroj","year":"2019","journal-title":"Figshare."},{"key":"ref-28","article-title":"CurcumaDataDictionary.","author":"B Chumworathayi","year":"2019","journal-title":"Figshare."},{"key":"ref-29","article-title":"Asia-Pacific regional obesity guidelines.","year":"1999"},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"28-34","DOI":"10.1016\/j.rgmx.2012.10.006","article-title":"[Prevalence of gastrointestinal symptoms in overweight and obese subjects: an epidemiologic study on a Mexican population].","volume":"78","author":"R Bernal-Reyes","year":"2013","journal-title":"Rev Gastroenterol Mex."},{"key":"ref-31","first-page":"247-52","article-title":"[Influence of obesity on dyspepsia symptoms].","volume":"75","author":"O Trujillo-Benavides","year":"2010","journal-title":"Rev Gastroenterol Mex."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/8-1827\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/8-1827\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/8-1827\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T10:39:06Z","timestamp":1610620746000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/8-1827\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":31,"URL":"https:\/\/doi.org\/10.12688\/f1000research.20662.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.22724.r74786","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.22724.r62820","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.22724.r74786","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.22724.r62820","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/8-1827\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.22724.r62820, Jie-ying Bai, Laboratory Animal Center, Academy of Military Medical Sciences, Beijing, China, 12 May 2020, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/8-1827\/v1#referee-response-62820","order":0,"name":"referee-response-62820","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"Bandit Chumworathayi<\/b>; \nPosted: 14 May 2020<\/i>; Thank you very much for your comments. Further research with larger sample size will be conducted.","URL":"https:\/\/f1000research.com\/articles\/8-1827\/v1#referee-comment-5505","order":1,"name":"referee-comment-5505","label":"Referee Comment","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.22724.r74786, Somsook Santibenchakul, Department of Obstetrics and Gynaecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, 14 Jan 2021, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/8-1827\/v1#referee-response-74786","order":2,"name":"referee-response-74786","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This study was supported by Khon Kaen Hospital (research grant number KE61020), approved on 14th February 2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":3,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}